Apo E structure determines VLDL clearance and atherosclerosis risk in mice

Area of Science:

• Biochemistry
• Genetics
• Cardiovascular Science

Background:

• Apolipoprotein E (apo E) is crucial for lipid metabolism.
• Different apo E isoforms (E2, E3, E4) are associated with varying cardiovascular disease risks.
• Understanding isoform-specific effects on lipid transport and atherosclerosis is vital.

Purpose of the Study:

• To investigate the functional consequences of the human apo E4 isoform compared to the apo E3 isoform in mice.
• To determine the impact of apo E isoform structure on very-low-density lipoprotein (VLDL) metabolism and atherosclerosis development.

Main Methods:

• Generated transgenic mice expressing human apo E4 (4/4) or apo E3 (3/3) in place of endogenous apo E.
• Analyzed plasma lipid and apolipoprotein levels on various diets.
• Assessed VLDL composition, VLDL receptor binding, and VLDL clearance rates.
• Quantified atherosclerotic plaque size in response to an atherogenic diet.

Main Results:

• No significant differences in plasma lipids between 4/4 and 3/3 mice on chow diet.
• 4/4 mice exhibited approximately double the cholesterol, apo E, and apo B-48 in their VLDL compared to 3/3 mice across all diets.
• 4/4 VLDL showed slightly enhanced binding to the LDL receptor but had a 50% reduced clearance rate compared to 3/3 VLDL.
• A trend towards larger atherosclerotic plaque size was observed in 4/4 mice on an atherogenic diet.

Conclusions:

• Structural differences in apo E protein isoforms are sufficient to alter VLDL residence time.
• Impaired VLDL clearance in apo E4 mice is linked to increased atherosclerosis risk.
• These findings highlight the direct role of apo E isoform structure in modulating lipoprotein metabolism and cardiovascular disease susceptibility.